Objective: Targeted magnetic resonance/ultrasound fusion prostate biopsy has been shown to improve the detection of high-grade prostate cancer and to reduce sampling errors. Our objective is to assess MR-TRUS targeted fusion biopsy versus standard biopsy for the detection of clinically significant tumors.
Materials And Methods: Patients were referred for abnormal digital rectal examination (DRE) or risen prostate-specific antigen (PSA).